Perampanel Hemifumarate Suppliers & Bulk Manufacturers
Available Forms: Tablets / Oral suspension
Available Strengths: 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, 12 mg
Reference Brands: Fycompa (USA/EU)
Category:
Neurology
Perampanel is an antiepileptic drug used to treat partial-onset seizures and primary generalized tonic-clonic seizures in patients with epilepsy. It acts as a selective, non-competitive antagonist of the AMPA receptor on postsynaptic neurons, reducing excessive neuronal excitation that can lead to seizures.
Perampanel hemifumarate is available in Tablets / Oral suspension
and strengths such as 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, 12 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Perampanel hemifumarate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Perampanel hemifumarate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing